scholarly article | Q13442814 |
P50 | author | Karl-Heinz Wagner | Q38362708 |
P2093 | author name string | Claudio Tiribelli | |
Andrew Cameron Bulmer | |||
Christine Mölzer | |||
Libor Vitek | |||
Marlies Wallner | |||
Silvia Gazzin | |||
P2860 | cites work | Biliverdin reductase: a major physiologic cytoprotectant | Q24541497 |
Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States | Q24649713 | ||
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation | Q26823454 | ||
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework | Q28203935 | ||
Proportions, odds, and risk | Q28236104 | ||
Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle | Q28264545 | ||
Bilirubin is an antioxidant of possible physiological importance | Q28288206 | ||
Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications | Q28306266 | ||
Disruption of adiponectin causes insulin resistance and neointimal formation | Q28589597 | ||
Proinflammatory cytokines in CRP baseline regulation | Q28645842 | ||
Venous collagenosis and arteriolar tortuosity in leukoaraiosis | Q30744693 | ||
Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance | Q31450908 | ||
Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study | Q31798350 | ||
Inflammation in atherosclerosis: from pathophysiology to practice | Q33709505 | ||
Body fat percentage is a major determinant of total bilirubin independently of UGT1A1*28 polymorphism in young obese. | Q33716871 | ||
Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship? | Q33891946 | ||
The enzymatic formation of bilirubin | Q34008296 | ||
Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues | Q34016276 | ||
Gene knockdowns in adult animals: PPMOs and vivo-morpholinos | Q34016744 | ||
Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels | Q34114552 | ||
The novel antidote Bezoar Bovis prevents the cardiotoxicity of Toad (Bufo bufo gargarizans Canto) Venom in mice | Q34150328 | ||
Moderate hyperbilirubinemia improves renal hemodynamics in ANG II-dependent hypertension | Q34212489 | ||
The effects of Gilbert's syndrome on the mean platelet volume and other hematological parameters | Q34324248 | ||
In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation | Q34445138 | ||
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide | Q34456855 | ||
Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. | Q34762005 | ||
Use of conventional and -omics based methods for health claims of dietary antioxidants: a critical overview. | Q34781792 | ||
Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients | Q34857822 | ||
Clinical application of C-reactive protein for cardiovascular disease detection and prevention | Q35054464 | ||
The relationship of the anti-oxidant bilirubin with free thyroxine is modified by insulin resistance in euthyroid subjects | Q35111409 | ||
The relationship between total bilirubin levels and total mortality in older adults: the United States National Health and Nutrition Examination Survey (NHANES) 1999-2004. | Q35146969 | ||
Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease? | Q35152249 | ||
Enterohepatic cycling of bilirubin as a cause of 'black' pigment gallstones in adult life. | Q35202140 | ||
Usefulness of serum bilirubin and cardiorespiratory fitness as predictors of mortality in men | Q35501103 | ||
C-reactive protein and atherothrombosis—Beyond a biomarker: an actual partaker of lesion formation | Q35558796 | ||
Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response | Q35607392 | ||
The role of estrogen in the initiation of breast cancer | Q35698844 | ||
Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress | Q35754477 | ||
The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases | Q35867073 | ||
Antioxidant activities of bile pigments | Q35877590 | ||
Essential roles of Raf/extracellular signal-regulated kinase/mitogen-activated protein kinase pathway, YY1, and Ca2+ influx in growth arrest of human vascular smooth muscle cells by bilirubin | Q35939840 | ||
Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome | Q36041536 | ||
Liver function from Y to Z | Q36129168 | ||
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine | Q36477929 | ||
Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease | Q36518887 | ||
Hormones and cardiovascular health in women | Q36522630 | ||
In vitro DNA-damaging effects of intestinal and related tetrapyrroles in human cancer cells. | Q36602357 | ||
Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment | Q36874545 | ||
Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study | Q36951478 | ||
Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. | Q37001252 | ||
Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression | Q37111515 | ||
Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? | Q37176133 | ||
Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury | Q37187635 | ||
Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia | Q37231225 | ||
Bilirubin and related tetrapyrroles inhibit food-borne mutagenesis: a mechanism for antigenotoxic action against a model epoxide. | Q37267060 | ||
Endothelial dysfunction over the course of coronary artery disease | Q37271463 | ||
Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk | Q37367666 | ||
Intraperitoneal bilirubin administration decreases infarct area in a rat coronary ischemia/reperfusion model. | Q37589637 | ||
Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation | Q37594114 | ||
Bilirubin chemistry and metabolism; harmful and protective aspects. | Q37597193 | ||
Complement activation and disease: protective effects of hyperbilirubinaemia | Q37609484 | ||
Using genetic variation for establishing causality of cardiovascular risk factors: overcoming confounding and reverse causality | Q37638455 | ||
Effects of total bilirubin on the prevalence of osteoporosis in postmenopausal women without potential liver disease | Q44173814 | ||
A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). | Q44185435 | ||
Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer. | Q44354909 | ||
Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study | Q44728568 | ||
Decreased plasma antioxidants in schizophrenia | Q44922740 | ||
Decreased serum bilirubin is associated with silent cerebral infarction | Q44994381 | ||
Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization | Q45070015 | ||
Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells | Q45758375 | ||
Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort | Q45781949 | ||
Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial. | Q46005132 | ||
Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome. | Q46036068 | ||
Unconjugated bilirubin inhibits collagen induced platelet activation | Q46202266 | ||
Elevated serum bilirubin levels are inversely associated with coronary artery atherosclerosis | Q46258727 | ||
Bilirubin influences the clinical presentation of pre-eclampsia | Q46319663 | ||
Relationship between serum bilirubin and coagulation test results in 1-month-old infants | Q46423625 | ||
Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. | Q46567179 | ||
Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation | Q46640973 | ||
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia | Q46710172 | ||
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial | Q46750170 | ||
Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection | Q46835713 | ||
Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis | Q46861795 | ||
Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. | Q46920723 | ||
Bilirubin attenuates bufadienolide-induced ventricular arrhythmias and cardiac dysfunction in guinea-pigs by reducing elevated intracellular Na(+) levels | Q46951504 | ||
Identification of bilirubin reduction products formed by Clostridium perfringens isolated from human neonatal fecal flora. | Q46965912 | ||
Guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health | Q47150964 | ||
Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood | Q47728093 | ||
Evaluation of early atherosclerosis in patients with inflammatory bowel disease | Q47956330 | ||
Significant association between leukoaraiosis and metabolic syndrome in healthy subjects | Q48151474 | ||
Unconjugated bilirubin restricts oligodendrocyte differentiation and axonal myelination | Q48327147 | ||
Tweaking the human circadian clock with light | Q48546874 | ||
Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. | Q48606292 | ||
Increased plasma bilirubin in Parkinson patients on L-dopa: evidence against the free radical hypothesis? | Q48733221 | ||
In vitro antioxidant capacity and antigenotoxic properties of protoporphyrin and structurally related tetrapyrroles | Q50025304 | ||
The anti-mutagenic and antioxidant effects of bile pigments in the Ames Salmonella test. | Q50073246 | ||
Experimental databases on inhibition of the bacterial mutagenicity of 4-nitroquinoline 1-oxide and cigarette smoke | Q50150276 | ||
Structural basis of antimutagenicity of chemicals towards 4-nitroquinoline 1-oxide in Salmonella typhimurium | Q50152914 | ||
Binding of polycyclic planar mutagens to chlorophyllin resulting in inhibition of the mutagenic activity | Q50162770 | ||
Reduced status of plasma total antioxidant capacity in schizophrenia. | Q50872362 | ||
Inverse association between total bilirubin and metabolic syndrome in rural korean women. | Q51027278 | ||
Bilirubin and biliverdin treatment of atherosclerotic diseases. | Q51081365 | ||
A decrease in total bilirubin predicted hyper-LDL cholesterolemia in a health screening population. | Q51321152 | ||
Increased serum bilirubin level is related to good collateral development in patients with chronic total coronary occlusion. | Q51361732 | ||
Relationship between bilirubin concentration, coronary endothelial function, and inflammatory stress in overweight patients. | Q51378364 | ||
Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. | Q51527378 | ||
Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis? | Q51809466 | ||
Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer's disease. | Q53236827 | ||
Mean platelet volume (MPV) is associated with leukoaraiosis in the apparently healthy elderly. | Q53398851 | ||
Bilirubin and the risk of common non-hepatic diseases. | Q53620391 | ||
Serum Bilirubin and Risk of Respiratory Disease and Death | Q56946006 | ||
Risk of Arterial Cardiovascular Diseases in Patients with Multiple Sclerosis: A Population-Based Cohort Study | Q57300407 | ||
Association of SULT1A1 and UGT1A1 polymorphisms with breast cancer risk and phenotypes in Russian women | Q57417473 | ||
Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study | Q57500367 | ||
Relationship between serum bilirubin and uric acid to oxidative stress markers in Italian and Czech populations | Q57825139 | ||
Leukoaraiosis is a chronic atherosclerotic disease | Q58914818 | ||
Enterohepatic Circulation of Bilirubin | Q58985369 | ||
Enterohepatic Circulation of Unconjugated Bilirubin in Man | Q59009964 | ||
Serum Bilirubin and Genes Controlling Bilirubin Concentrations as Biomarkers for Cardiovascular Disease | Q37778668 | ||
Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies | Q37821663 | ||
Association of lower total bilirubin level with statin usage: the United States National Health and Nutrition Examination Survey 1999-2008. | Q37917068 | ||
A global view on the development of non communicable diseases | Q37969475 | ||
Triglycerides: how much credit do they deserve? | Q37990662 | ||
Increased cardiovascular risk in patients with chronic obstructive pulmonary disease and the potential mechanisms linking the two conditions: a review. | Q38055312 | ||
Bilirubin and beyond: a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection. | Q38064194 | ||
A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes | Q38131559 | ||
Cardiovascular risk and psoriasis: beyond the traditional risk factors | Q38155667 | ||
Bilirubin-induced neurologic damage--mechanisms and management approaches. | Q38164429 | ||
Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations. | Q38206770 | ||
Mean platelet volume and coronary artery disease: a systematic review and meta-analysis | Q38228969 | ||
Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert's syndrome? | Q38313639 | ||
Circulating total bilirubin and risk of incident cardiovascular disease in the general population | Q38320191 | ||
Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway | Q39048243 | ||
Heme modulates smooth muscle cell proliferation and migration via NADPH oxidase: a counter-regulatory role for heme oxygenase system. | Q39284239 | ||
Higher serum bilirubin level as a protective factor for the development of diabetes in healthy Korean men: a 4 year retrospective longitudinal study. | Q39329849 | ||
Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia. | Q39420938 | ||
Serum total bilirubin concentration is inversely correlated with Framingham risk score in Koreans. | Q39616387 | ||
Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules. | Q39838684 | ||
Association between serum total bilirubin level and leukoaraiosis in Korean adults. | Q40016158 | ||
Bilirubin inhibits tumor cell growth via activation of ERK. | Q40036603 | ||
Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. | Q40097808 | ||
Bilirubin exhibits a novel anti-cancer effect on human adenocarcinoma | Q40309013 | ||
Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. | Q40450014 | ||
Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: a randomized clinical trial | Q41666586 | ||
Extracellular and intracellular anti-mutagenic effects of bile pigments in the Salmonella typhimurium reverse mutation assay | Q42087685 | ||
Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes | Q42705322 | ||
Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer | Q42748889 | ||
Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women | Q43190787 | ||
High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions | Q43495784 | ||
Serum total bilirubin is inversely associated with brachial-ankle pulse wave velocity in men with hypertension. | Q43546006 | ||
Hyperbilirubinemia modulates myocardial function, aortic ejection, and ischemic stress resistance in the Gunn rat. | Q43578671 | ||
Serum bilirubin levels and risk of prediabetes in young and healthy adults | Q43636608 | ||
Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children. | Q44126730 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1-25 | |
P577 | publication date | 2015-07-01 | |
P1433 | published in | Clinical Science | Q372419 |
P1476 | title | Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases | |
P478 | volume | 129 |
Q54323486 | Amelioration of thioacetamide-induced liver toxicity in Wistar rats by rutin. |
Q33872752 | Association between Hemoglobin Levels and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes: A Cross-Sectional Study Using Electronic Health Records. |
Q60926275 | Beyond a Measure of Liver Function-Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients |
Q90906251 | Bilirubin and Ischemic Stroke: Rendering the Current Paradigm to Better Understand the Protective Effects of Bilirubin |
Q89524865 | Bilirubin as a signaling molecule |
Q28071435 | Bilirubin in coronary artery disease: Cytotoxic or protective? |
Q37067651 | Bilirubin is an Endogenous Antioxidant in Human Vascular Endothelial Cells |
Q26748324 | Biomarkers of Aging: From Function to Molecular Biology |
Q89678032 | Carbon monoxide breath test assessment of mild hemolysis in Gilbert's syndrome |
Q33677943 | Characteristics of the heme catabolic pathway in mild unconjugated hyperbilirubinemia and their associations with inflammation and disease prevention |
Q38957221 | Chronically elevated bilirubin protects from cardiac reperfusion injury in the male Gunn rat. |
Q37460666 | Circulating cell-free DNA, telomere length and bilirubin in the Vienna Active Ageing Study: exploratory analysis of a randomized, controlled trial. |
Q40395687 | Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure. |
Q39012956 | Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment |
Q37116706 | Features of an altered AMPK metabolic pathway in Gilbert's Syndrome, and its role in metabolic health |
Q89820050 | Heme Oxygenase Dependent Bilirubin Generation in Vascular Cells: A Role in Preventing Endothelial Dysfunction in Local Tissue Microenvironment? |
Q38823562 | Heme Oxygenases in Cardiovascular Health and Disease |
Q37418046 | Higher hydrocortisone dose increases bilirubin in hypopituitary patients- results from an RCT. |
Q37172167 | Hyperbilirubinemia Protects against Aging-Associated Inflammation and Metabolic Deterioration. |
Q91924929 | Hyperbilirubinemia in Gunn Rats is Associated with Decreased Inflammatory Response in LPS-Mediated Systemic Inflammation |
Q64229422 | Isolated Silymarin Flavonoids Increase Systemic and Hepatic Bilirubin Concentrations and Lower Lipoperoxidation in Mice |
Q92242788 | LED-phototherapy does not induce oxidative DNA damage in hyperbilirubinemic Gunn rats |
Q36633410 | Longer telomeres in chronic, moderate, unconjugated hyperbilirubinaemia: insights from a human study on Gilbert's Syndrome |
Q46225090 | Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα. |
Q49979401 | Relationship between serum bilirubin levels and cardiovascular disease |
Q41689988 | Serum Bilirubin Levels and Promoter Variations in HMOX1 and UGT1A1 Genes in Patients with Fabry Disease |
Q26738400 | Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone Metastases |
Q99708873 | The Role of Bilirubin and the Other "Yellow Players" in Neurodegenerative Diseases |
Q39048488 | The molecular basis of jaundice: An old symptom revisited. |
Q40291987 | UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population |
Search more.